APOE and Alzheimer disease: Susceptibility to developing AD after chemotherapy exposure could relate to genotype (ie, APOE status), specific chemotherapeutic regimen, accumulated dose of chemotherapy, age at time of treatment, and other factors modulating the pathways as described in this review.